Provided by Tiger Trade Technology Pte. Ltd.

IGC Pharma

0.2979
-0.0082-2.68%
Post-market: 0.30000.0021+0.70%19:56 EST
Volume:395.61K
Turnover:118.86K
Market Cap:27.67M
PE:-3.82
High:0.3112
Open:0.3083
Low:0.2951
Close:0.3061
52wk High:0.4985
52wk Low:0.2525
Shares:92.87M
Float Shares:83.13M
Volume Ratio:1.16
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0780
EPS(LYR):-0.0931
ROE:-83.34%
ROA:-50.31%
PB:3.42
PE(LYR):-3.20

Loading ...

Press Release: NeoVolta Enters into Definitive Agreements Led by Infinite Grid Capital to Advance 2 GWh U.S. Battery Energy Storage System Manufacturing Initiative

Dow Jones
·
Nov 24

IGC Pharma Reports Progress Amid Financial Losses

TIPRANKS
·
Nov 18

IGC Pharma expects ‘continued strong momentum’ into 2H26

TIPRANKS
·
Nov 17

IGC Pharma Q2 EPS $(0.02), Inline, Sales $191.000K Miss $325.000K Estimate

Benzinga
·
Nov 17

IGC Pharma Sells Non-Core Facility for $2.7 Million

Reuters
·
Nov 17

IGC Pharma files to sell 978,235 shares of common stock for holders

TIPRANKS
·
Nov 17

IGC Pharma Reports Lower Revenue Amid Shift to Alzheimer’s Drug Development

Reuters
·
Nov 15

IGC Pharma Sells Vancouver Assets to Wellness Essentials

TIPRANKS
·
Nov 14

IGC Pharma Granted U.S. Patent for Novel Alzheimer's Drug Composition Targeting CNS Disorders

Reuters
·
Nov 13

IGC Pharma expands Phase 2 CALMA trial to University of South Florida

TIPRANKS
·
Oct 14

IGC Pharma Inc. Held Annual Meeting of Stockholders

Reuters
·
Oct 14

IGC Pharma announces in-vitro preclinical data for IGC-1C

TIPRANKS
·
Oct 07

IGC Pharma Announces Promising Preclinical Results for IGC-1C, a Novel Drug Candidate Targeting Tau Protein in Alzheimer’s Disease

Reuters
·
Oct 07

Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025

GlobeNewswire
·
Oct 06

IGC Pharma Subsidiary Signs Asset Sale Agreement

TIPRANKS
·
Oct 02

Corrected-IGC Pharma Inc - Unit Enters Sale of Assets Agreement for $2.7 Mln - SEC Filing (Adds Dropped Currency Symbol)

THOMSON REUTERS
·
Oct 02

BRIEF-IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing

Reuters
·
Oct 02

IGC Pharma Sells Holi Hemp Assets to Wellness Essentials Northwest in $2.7 Million Deal

Reuters
·
Oct 02

IGC Pharma expands CALMA Phase 2 trial with Ichor Research site

TIPRANKS
·
Sep 29

IGC Pharma Announces Promising Preclinical Results for TGR-63, a Dual-Acting Alzheimer's Drug Targeting Beta-Amyloid and Tau Pathology

Reuters
·
Sep 24